Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Medtronic
Queensland Health
McKesson
Mallinckrodt
Johnson and Johnson
Argus Health
Colorcon
Cipla

Generated: April 26, 2018

DrugPatentWatch Database Preview

CEFZIL Drug Profile

« Back to Dashboard

When do Cefzil patents expire, and when can generic versions of Cefzil launch?

Cefzil is a drug marketed by Corden Pharma and is included in two NDAs.

The generic ingredient in CEFZIL is cefprozil. There are thirteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the cefprozil profile page.
Drug patent expirations by year for CEFZIL
Synonyms for CEFZIL
(6R,7R)-7-((R)-2-amino-2-(4-hydroxyphenyl)acetamido)-8-oxo-3-((E)-prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate
(6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-8-oxo-3-propenyl-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
(6R,7R)-7-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate
(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate
(6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6S,7R)-7-((R)-2-Amino-2-(4-hydroxyphenyl)acetamido)-8-oxo-3-((E)-prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
111900-24-4
121123-17-9
123C179
3ADV90MJVU
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2R)-amino(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-(1-propenyl)-, (6R,7R)-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-(1-propenyl)-, (6R-(6alpha,7beta(R*)))-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-(1-propenyl)-, monohydrate, (6R-(6alpha,7beta(R*)))-
5-Thia-1-azabicyclo(4.2.0)oct-2-oxo-2-carboxylic acid, 7-(((2R)-amino(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-(1-propenyl)-, monohydrate, (6R,7R)-
5-Thia-1-azabicyclo(4.2.0)oct-2-oxo-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-(1-propenyl)-, monohydrate, (6R-(6alpha,7beta(R*))-)-
665C297
92665-29-7
A-8944
AB01274812_02
AB01274812-01
AB2000641
AC1NQXVS
AC1O5M2K
AKOS015895264
AKOS015895989
ALYUMNAHLSSTOU-CIRGZYLNSA-N
AN-14731
API0001909
Arzimol
AS-14301
BC208630
BIDD:GT0833
BMY 28100
BMY-28100-03-800
Brisoral
C06888
C18H19N3O5S.C2H6O
CCG-221280
cefprozil
Cefprozil (INN)
Cefprozil (monohydrate)
Cefprozil (TN)
Cefprozil (USP)
Cefprozil [USAN:INN]
Cefprozil [USAN:USP:INN:BAN]
Cefprozil [USAN]
Cefprozil anhydrous
Cefprozil anhydrous, e-isomer
Cefprozil hydrate
Cefprozil hydrate (Cefzil)
Cefprozil monohydrate
Cefprozil, (E)-
Cefprozil, mix of Z (92%), and E (7%) isomers
Cefprozil;Cefzil
cefprozile
Cefprozilo
Cefprozilo [INN-Spanish]
Cefprozilum
Cefprozilum [INN-Latin]
Cefzil (TN)
cephprozyl
CFPZ
CHEBI:3506
CHEMBL276568
Cronocef
CS-2569
D00261
D07651
D0YX4S
DB01150
DR002251
DR002414
E-Cefprozil
HE301539
HE416842
HY-B0458
I06-1766
J-004449
KB-277434
KS-1039
LS-149959
LS-172480
MFCD00911719
MolPort-006-823-790
Procef
Procef (TN)
S1SDI2FJIY
s2544
SCHEMBL1230160
SCHEMBL37024
SCHEMBL718721
Serozil
ST51052844
trans-Cefprozil
UNII-1M698F4H4E component WDLWHQDACQUCJR-ZAMMOSSLSA-N
UNII-3ADV90MJVU
UNII-4W0459ZA4V component ALYUMNAHLSSTOU-CIRGZYLNSA-N
UNII-S1SDI2FJIY
WDLWHQDACQUCJR-ZAMMOSSLSA-N
ZINC3776970

US Patents and Regulatory Information for CEFZIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Corden Pharma CEFZIL cefprozil FOR SUSPENSION;ORAL 050665-001 Dec 23, 1991 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Corden Pharma CEFZIL cefprozil TABLET;ORAL 050664-002 Dec 23, 1991 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Corden Pharma CEFZIL cefprozil FOR SUSPENSION;ORAL 050665-002 Dec 23, 1991 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Corden Pharma CEFZIL cefprozil TABLET;ORAL 050664-001 Dec 23, 1991 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Teva
Accenture
Julphar
McKesson
QuintilesIMS
US Department of Justice
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.